212 related articles for article (PubMed ID: 17360658)
1. Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression.
Yanai H; Chen HM; Inuzuka T; Kondo S; Mak TW; Takaoka A; Honda K; Taniguchi T
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3402-7. PubMed ID: 17360658
[TBL] [Abstract][Full Text] [Related]
2. Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.
Takaoka A; Hayakawa S; Yanai H; Stoiber D; Negishi H; Kikuchi H; Sasaki S; Imai K; Shibue T; Honda K; Taniguchi T
Nature; 2003 Jul; 424(6948):516-23. PubMed ID: 12872134
[TBL] [Abstract][Full Text] [Related]
3. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors.
Honda K; Takaoka A; Taniguchi T
Immunity; 2006 Sep; 25(3):349-60. PubMed ID: 16979567
[TBL] [Abstract][Full Text] [Related]
4. Binding of Kaposi's sarcoma-associated herpesvirus K-bZIP to interferon-responsive factor 3 elements modulates antiviral gene expression.
Lefort S; Soucy-Faulkner A; Grandvaux N; Flamand L
J Virol; 2007 Oct; 81(20):10950-60. PubMed ID: 17652396
[TBL] [Abstract][Full Text] [Related]
5. The genetics and biology of Irf5-mediated signaling in lupus.
Kozyrev SV; Alarcon-Riquelme ME
Autoimmunity; 2007 Dec; 40(8):591-601. PubMed ID: 18075793
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the type I IFN induction: a current view.
Honda K; Yanai H; Takaoka A; Taniguchi T
Int Immunol; 2005 Nov; 17(11):1367-78. PubMed ID: 16214811
[TBL] [Abstract][Full Text] [Related]
7. Intragraft TNF receptor signaling contributes to activation of innate and adaptive immunity in a renal allograft model.
Hummel M; Kurian SM; Lin S; Borodyanskiy A; Zhang Z; Li Z; Kim SJ; Salomon DR; Abecassis M
Transplantation; 2009 Jan; 87(2):178-88. PubMed ID: 19155971
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells.
Rincon-Orozco B; Halec G; Rosenberger S; Muschik D; Nindl I; Bachmann A; Ritter TM; Dondog B; Ly R; Bosch FX; Zawatzky R; Rösl F
Cancer Res; 2009 Nov; 69(22):8718-25. PubMed ID: 19887612
[TBL] [Abstract][Full Text] [Related]
9. Homeostatic erythropoiesis by the transcription factor IRF2 through attenuation of type I interferon signaling.
Mizutani T; Tsuji K; Ebihara Y; Taki S; Ohba Y; Taniguchi T; Honda K
Exp Hematol; 2008 Mar; 36(3):255-64. PubMed ID: 18207304
[TBL] [Abstract][Full Text] [Related]
10. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus.
Kozyrev SV; Lewén S; Reddy PM; Pons-Estel B; ; Witte T; ; Junker P; Laustrup H; Gutiérrez C; Suárez A; Francisca González-Escribano M; Martín J; ; Alarcón-Riquelme ME
Arthritis Rheum; 2007 Apr; 56(4):1234-41. PubMed ID: 17393452
[TBL] [Abstract][Full Text] [Related]
11. Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages.
Xu H; An H; Hou J; Han C; Wang P; Yu Y; Cao X
Mol Immunol; 2008 Aug; 45(13):3545-52. PubMed ID: 18571728
[TBL] [Abstract][Full Text] [Related]
12. Role for Kruppel-like factor 4 in determining the outcome of p53 response to DNA damage.
Zhou Q; Hong Y; Zhan Q; Shen Y; Liu Z
Cancer Res; 2009 Nov; 69(21):8284-92. PubMed ID: 19826046
[TBL] [Abstract][Full Text] [Related]
13. Signal regulatory protein alpha negatively regulates both TLR3 and cytoplasmic pathways in type I interferon induction.
Dong LW; Kong XN; Yan HX; Yu LX; Chen L; Yang W; Liu Q; Huang DD; Wu MC; Wang HY
Mol Immunol; 2008 Jun; 45(11):3025-35. PubMed ID: 18471880
[TBL] [Abstract][Full Text] [Related]
14. Apoptotic effect of Biophytum sensitivum on B16F-10 cells and its regulatory effects on nitric oxide and cytokine production on tumor-associated macrophages.
Guruvayoorappan C; Kuttan G
Integr Cancer Ther; 2007 Dec; 6(4):373-80. PubMed ID: 18048885
[TBL] [Abstract][Full Text] [Related]
15. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
[TBL] [Abstract][Full Text] [Related]
16. Variants of the interferon regulatory factor 5 gene regulate expression of IRF5 mRNA in atherosclerotic tissue but are not associated with myocardial infarction.
Mälarstig A; Sigurdsson S; Eriksson P; Paulsson-Berne G; Hedin U; Wallentin L; Siegbahn A; Hamsten A; Syvänen AC
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):975-82. PubMed ID: 18323517
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of interferon regulatory factor 5 and its role in the innate antiviral immune response.
Ai K; Luo K; Xia L; Gao W; Hu W; Qi Z; Xu Q
Fish Shellfish Immunol; 2018 Jan; 72():31-36. PubMed ID: 29080685
[TBL] [Abstract][Full Text] [Related]
18. Differential requirement of histone acetylase and deacetylase activities for IRF5-mediated proinflammatory cytokine expression.
Feng D; Sangster-Guity N; Stone R; Korczeniewska J; Mancl ME; Fitzgerald-Bocarsly P; Barnes BJ
J Immunol; 2010 Nov; 185(10):6003-12. PubMed ID: 20935208
[TBL] [Abstract][Full Text] [Related]
19. A cell-type-specific requirement for IFN regulatory factor 5 (IRF5) in Fas-induced apoptosis.
Couzinet A; Tamura K; Chen HM; Nishimura K; Wang Z; Morishita Y; Takeda K; Yagita H; Yanai H; Taniguchi T; Tamura T
Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2556-61. PubMed ID: 18268344
[TBL] [Abstract][Full Text] [Related]
20. Regulating IRFs in IFN Driven Disease.
Jefferies CA
Front Immunol; 2019; 10():325. PubMed ID: 30984161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
